Women, power, and cancer: a Lancet Commission

Ophira Ginsburg; Verna Vanderpuye; Ann Marie Beddoe; Nirmala Bhoo-Pathy; Freddie Bray; Carlo Caduff; Narjust Florez; Ibtihal Fadhil; Nazik Hammad; Shirin Heidari; Ishu Kataria; Somesh Kumar; Erica Liebermann; Jennifer Moodley; Miriam Mutebi; Deborah Mukherji; Rachel Nugent; Winnie K.W. So; Enrique Soto-Perez-de-Celis; Karla Unger-Saldaña; Gavin Allman; Jenna Bhimani; María T. Bourlon; Michelle A.B. Eala; Peter S. Hovmand; Yek Ching Kong; Sonia Menon; Carolyn D. Taylor; Isabelle Soerjomataram

doi:10.1016/S0140-6736(23)01701-4

Women, power, and cancer: a Lancet Commission

Ophira Ginsburg, Verna Vanderpuye, Ann Marie Beddoe, Nirmala Bhoo-Pathy, Freddie Bray, Carlo Caduff, Narjust Florez, Ibtihal Fadhil, Nazik Hammad, Shirin Heidari, Ishu Kataria, Somesh Kumar, Erica Liebermann, Jennifer Moodley, Miriam Mutebi, Deborah Mukherji, Rachel Nugent, Winnie K.W. So, Enrique Soto-Perez-de-Celis, Karla Unger-SaldañaGavin Allman, Jenna Bhimani, María T. Bourlon, Michelle A.B. Eala, Peter S. Hovmand, Yek Ching Kong, Sonia Menon, Carolyn D. Taylor, Isabelle Soerjomataram

Research output: Contribution to journal › Review article › peer-review

95 Citations (Scopus)

Original language	English (US)
Pages (from-to)	2113-2166
Number of pages	54
Journal	The Lancet
Volume	402
Issue number	10417
DOIs	https://doi.org/10.1016/S0140-6736(23)01701-4
Publication status	Published - 2 Dec 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(23)01701-4

Cite this

Ginsburg, O., Vanderpuye, V., Beddoe, A. M., Bhoo-Pathy, N., Bray, F., Caduff, C., Florez, N., Fadhil, I., Hammad, N., Heidari, S., Kataria, I., Kumar, S., Liebermann, E., Moodley, J., Mutebi, M., Mukherji, D., Nugent, R., So, W. K. W., Soto-Perez-de-Celis, E., ... Soerjomataram, I. (2023). Women, power, and cancer: a Lancet Commission. The Lancet, 402(10417), 2113-2166. https://doi.org/10.1016/S0140-6736(23)01701-4

@article{22232673fc08455eb8172b36b2bcbfcc,

title = "Women, power, and cancer: a Lancet Commission",

author = "Ophira Ginsburg and Verna Vanderpuye and Beddoe, \{Ann Marie\} and Nirmala Bhoo-Pathy and Freddie Bray and Carlo Caduff and Narjust Florez and Ibtihal Fadhil and Nazik Hammad and Shirin Heidari and Ishu Kataria and Somesh Kumar and Erica Liebermann and Jennifer Moodley and Miriam Mutebi and Deborah Mukherji and Rachel Nugent and So, \{Winnie K.W.\} and Enrique Soto-Perez-de-Celis and Karla Unger-Salda{\~n}a and Gavin Allman and Jenna Bhimani and Bourlon, \{Mar{\'i}a T.\} and Eala, \{Michelle A.B.\} and Hovmand, \{Peter S.\} and Kong, \{Yek Ching\} and Sonia Menon and Taylor, \{Carolyn D.\} and Isabelle Soerjomataram",

note = "Funding Information: There was no major funding for this work. The opinions expressed by the authors are their own and this material should not be interpreted as representing the official viewpoint of the US Department of Health and Human Services, the National Institutes of Health, or the National Cancer Institute. For cases in which authors are identified as personnel of the International Agency for Research on Cancer (IARC) or WHO, the authors alone are responsible for the views expressed in this Commission and they do not necessarily represent the decisions, policy, or views of the IARC or WHO. OG was supported in part by the IARC as a visiting scientist. We warmly thank The ACTION STUDY GROUP for providing data to estimate out-of-pocket expenditure for women with cancer in southeast Asia: Soe Aung, Viroath Heng, Stephen Jan, Merel Kimman, Glo Cristal Luna, Htun Lwin Nyein, Corazon A Ngelange, Irisyl Orolfo Real, Win Pa Pa Naing, Somphob Sangkittipaiboon, Shridevi Subramaniam, Hasbullah Thabrany, and Cheng-Har Yip. We thank Valerie McCormack, Clara Frick, Harriet Rumgay, Doreen WH Au, Hyo-Sook Bae, Qinqin Chen, Meritxell Mallafr{\'e} Larrosa, and Binbin Xu who commented on early discussions of the Commission or contributed to specific data, information, or graphics of the report. We warmly thank our advisors for their most helpful support and advice: Eduardo L Cazap, Lynette Denny, Julie Gralow, Hayley Jones, Sharon Kapambwe, Ana Langer, Devaki Nambiar, Christian Ntzimira, Solange Peters, Anna Shakarishvili, Lisa Stevens, and Richard Sullivan. We would like to express our deepest thanks to our Patient Advocacy Committee for their invaluable contributions: Piga Fern{\'a}ndez, Nela Hasi{\'c}, Kara Magsanoc-Alikpala, Gertrude Nakigudde, Abish G Romero Ju{\'a}rez, and Eman Shannan. Author CDT is Chair of the Patient Advocacy Committee and provided valuable advice during the conduct of the Commission. Our sincere thanks and deep gratitude for the individuals who facilitated the processes to document stories presented in the report and for the individuals who generously shared their personal stories (named or anonymously): Oumou Kassambara, Cheng Har Yip, Lama Andari, Gloria Bille, Vincent Cubaka, Marc Hagenimana, Claire Rieux, NFN Scout, Matthew B Schabath, Francois Uwinkindi, and Lydia E Pace. We would like to warmly thank Maria Castrillo Gil, Mary Guereva, and Danny Burke from eCancer for their invaluable and unwavering institutional support with the Commission's communications including website, in-person Commissioners' first meeting, and launch activities. Our sincerest thanks to Katiuska Veselinovi{\'c} at the IARC, for her tireless administrative work in supporting the coordination of the Commission's activities and manuscript preparation, and to Alicia A Livinski at the US National Cancer Institute for literature searches and reference management. We would also like to thank Elise M Garton and Nina Ghanem at the US National Cancer Institute for their support in the Commission's communications. We are pleased to acknowledge partners of the Commission: American Association for Cancer Research, The African Cancer for Research on End of Life Care, African Organisation for Research and Training in Cancer, American Society of Clinical Oncology, European Society for Medical Oncology, GENDRO, George Institute for Global Health, Global Focus on Cancer, International Atomic Energy Agency, IARC, International Society of Nurses in Cancer Care, Joint United Nations Programme on HIV/AIDS, Institute of Cancer Policy-King's College London, The McCabe Centre, M{\'e}decins Sans Fronti{\`e}res, US National Cancer Institute Center for Global Health, Latin American and Caribbean Society of Medical Oncology, The Women Global Cancer Initiative, and the Union for International Cancer Control. Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations. Funding Information: There was no major funding for this work. The opinions expressed by the authors are their own and this material should not be interpreted as representing the official viewpoint of the US Department of Health and Human Services, the National Institutes of Health, or the National Cancer Institute. For cases in which authors are identified as personnel of the International Agency for Research on Cancer (IARC) or WHO, the authors alone are responsible for the views expressed in this Commission and they do not necessarily represent the decisions, policy, or views of the IARC or WHO. OG was supported in part by the IARC as a visiting scientist. We warmly thank The ACTION STUDY GROUP for providing data to estimate out-of-pocket expenditure for women with cancer in southeast Asia: Soe Aung, Viroath Heng, Stephen Jan, Merel Kimman, Glo Cristal Luna, Htun Lwin Nyein, Corazon A Ngelange, Irisyl Orolfo Real, Win Pa Pa Naing, Somphob Sangkittipaiboon, Shridevi Subramaniam, Hasbullah Thabrany, and Cheng-Har Yip. We thank Valerie McCormack, Clara Frick, Harriet Rumgay, Doreen WH Au, Hyo-Sook Bae, Qinqin Chen, Meritxell Mallafr{\'e} Larrosa, and Binbin Xu who commented on early discussions of the Commission or contributed to specific data, information, or graphics of the report. We warmly thank our advisors for their most helpful support and advice: Eduardo L Cazap, Lynette Denny, Julie Gralow, Hayley Jones, Sharon Kapambwe, Ana Langer, Devaki Nambiar, Christian Ntzimira, Solange Peters, Anna Shakarishvili, Lisa Stevens, and Richard Sullivan. We would like to express our deepest thanks to our Patient Advocacy Committee for their invaluable contributions: Piga Fern{\'a}ndez, Nela Hasi{\'c}, Kara Magsanoc-Alikpala, Gertrude Nakigudde, Abish G Romero Ju{\'a}rez, and Eman Shannan. Author CDT is Chair of the Patient Advocacy Committee and provided valuable advice during the conduct of the Commission. Our sincere thanks and deep gratitude for the individuals who facilitated the processes to document stories presented in the report and for the individuals who generously shared their personal stories (named or anonymously): Oumou Kassambara, Cheng Har Yip, Lama Andari, Gloria Bille, Vincent Cubaka, Marc Hagenimana, Claire Rieux, NFN Scout, Matthew B Schabath, Francois Uwinkindi, and Lydia E Pace. We would like to warmly thank Maria Castrillo Gil, Mary Guereva, and Danny Burke from eCancer for their invaluable and unwavering institutional support with the Commission's communications including website, in-person Commissioners' first meeting, and launch activities. Our sincerest thanks to Katiuska Veselinovi{\'c} at the IARC, for her tireless administrative work in supporting the coordination of the Commission's activities and manuscript preparation, and to Alicia A Livinski at the US National Cancer Institute for literature searches and reference management. We would also like to thank Elise M Garton and Nina Ghanem at the US National Cancer Institute for their support in the Commission's communications. We are pleased to acknowledge partners of the Commission: American Association for Cancer Research, The African Cancer for Research on End of Life Care, African Organisation for Research and Training in Cancer, American Society of Clinical Oncology, European Society for Medical Oncology, GENDRO, George Institute for Global Health, Global Focus on Cancer, International Atomic Energy Agency, IARC, International Society of Nurses in Cancer Care, Joint United Nations Programme on HIV/AIDS, Institute of Cancer Policy-King's College London, The McCabe Centre, M{\'e}decins Sans Fronti{\`e}res, US National Cancer Institute Center for Global Health, Latin American and Caribbean Society of Medical Oncology, The Women Global Cancer Initiative, and the Union for International Cancer Control. ",

year = "2023",

month = dec,

day = "2",

doi = "10.1016/S0140-6736(23)01701-4",

language = "English (US)",

volume = "402",

pages = "2113--2166",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "10417",

}

Ginsburg, O, Vanderpuye, V, Beddoe, AM, Bhoo-Pathy, N, Bray, F, Caduff, C, Florez, N, Fadhil, I, Hammad, N, Heidari, S, Kataria, I, Kumar, S, Liebermann, E, Moodley, J, Mutebi, M, Mukherji, D, Nugent, R, So, WKW, Soto-Perez-de-Celis, E, Unger-Saldaña, K, Allman, G, Bhimani, J, Bourlon, MT, Eala, MAB, Hovmand, PS, Kong, YC, Menon, S, Taylor, CD & Soerjomataram, I 2023, 'Women, power, and cancer: a Lancet Commission', The Lancet, vol. 402, no. 10417, pp. 2113-2166. https://doi.org/10.1016/S0140-6736(23)01701-4

TY - JOUR

T1 - Women, power, and cancer

T2 - a Lancet Commission

AU - Ginsburg, Ophira

AU - Vanderpuye, Verna

AU - Beddoe, Ann Marie

AU - Bhoo-Pathy, Nirmala

AU - Bray, Freddie

AU - Caduff, Carlo

AU - Florez, Narjust

AU - Fadhil, Ibtihal

AU - Hammad, Nazik

AU - Heidari, Shirin

AU - Kataria, Ishu

AU - Kumar, Somesh

AU - Liebermann, Erica

AU - Moodley, Jennifer

AU - Mutebi, Miriam

AU - Mukherji, Deborah

AU - Nugent, Rachel

AU - So, Winnie K.W.

AU - Soto-Perez-de-Celis, Enrique

AU - Unger-Saldaña, Karla

AU - Allman, Gavin

AU - Bhimani, Jenna

AU - Bourlon, María T.

AU - Eala, Michelle A.B.

AU - Hovmand, Peter S.

AU - Kong, Yek Ching

AU - Menon, Sonia

AU - Taylor, Carolyn D.

AU - Soerjomataram, Isabelle

N1 - Funding Information: There was no major funding for this work. The opinions expressed by the authors are their own and this material should not be interpreted as representing the official viewpoint of the US Department of Health and Human Services, the National Institutes of Health, or the National Cancer Institute. For cases in which authors are identified as personnel of the International Agency for Research on Cancer (IARC) or WHO, the authors alone are responsible for the views expressed in this Commission and they do not necessarily represent the decisions, policy, or views of the IARC or WHO. OG was supported in part by the IARC as a visiting scientist. We warmly thank The ACTION STUDY GROUP for providing data to estimate out-of-pocket expenditure for women with cancer in southeast Asia: Soe Aung, Viroath Heng, Stephen Jan, Merel Kimman, Glo Cristal Luna, Htun Lwin Nyein, Corazon A Ngelange, Irisyl Orolfo Real, Win Pa Pa Naing, Somphob Sangkittipaiboon, Shridevi Subramaniam, Hasbullah Thabrany, and Cheng-Har Yip. We thank Valerie McCormack, Clara Frick, Harriet Rumgay, Doreen WH Au, Hyo-Sook Bae, Qinqin Chen, Meritxell Mallafré Larrosa, and Binbin Xu who commented on early discussions of the Commission or contributed to specific data, information, or graphics of the report. We warmly thank our advisors for their most helpful support and advice: Eduardo L Cazap, Lynette Denny, Julie Gralow, Hayley Jones, Sharon Kapambwe, Ana Langer, Devaki Nambiar, Christian Ntzimira, Solange Peters, Anna Shakarishvili, Lisa Stevens, and Richard Sullivan. We would like to express our deepest thanks to our Patient Advocacy Committee for their invaluable contributions: Piga Fernández, Nela Hasić, Kara Magsanoc-Alikpala, Gertrude Nakigudde, Abish G Romero Juárez, and Eman Shannan. Author CDT is Chair of the Patient Advocacy Committee and provided valuable advice during the conduct of the Commission. Our sincere thanks and deep gratitude for the individuals who facilitated the processes to document stories presented in the report and for the individuals who generously shared their personal stories (named or anonymously): Oumou Kassambara, Cheng Har Yip, Lama Andari, Gloria Bille, Vincent Cubaka, Marc Hagenimana, Claire Rieux, NFN Scout, Matthew B Schabath, Francois Uwinkindi, and Lydia E Pace. We would like to warmly thank Maria Castrillo Gil, Mary Guereva, and Danny Burke from eCancer for their invaluable and unwavering institutional support with the Commission's communications including website, in-person Commissioners' first meeting, and launch activities. Our sincerest thanks to Katiuska Veselinović at the IARC, for her tireless administrative work in supporting the coordination of the Commission's activities and manuscript preparation, and to Alicia A Livinski at the US National Cancer Institute for literature searches and reference management. We would also like to thank Elise M Garton and Nina Ghanem at the US National Cancer Institute for their support in the Commission's communications. We are pleased to acknowledge partners of the Commission: American Association for Cancer Research, The African Cancer for Research on End of Life Care, African Organisation for Research and Training in Cancer, American Society of Clinical Oncology, European Society for Medical Oncology, GENDRO, George Institute for Global Health, Global Focus on Cancer, International Atomic Energy Agency, IARC, International Society of Nurses in Cancer Care, Joint United Nations Programme on HIV/AIDS, Institute of Cancer Policy-King's College London, The McCabe Centre, Médecins Sans Frontières, US National Cancer Institute Center for Global Health, Latin American and Caribbean Society of Medical Oncology, The Women Global Cancer Initiative, and the Union for International Cancer Control. Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations. Funding Information: There was no major funding for this work. The opinions expressed by the authors are their own and this material should not be interpreted as representing the official viewpoint of the US Department of Health and Human Services, the National Institutes of Health, or the National Cancer Institute. For cases in which authors are identified as personnel of the International Agency for Research on Cancer (IARC) or WHO, the authors alone are responsible for the views expressed in this Commission and they do not necessarily represent the decisions, policy, or views of the IARC or WHO. OG was supported in part by the IARC as a visiting scientist. We warmly thank The ACTION STUDY GROUP for providing data to estimate out-of-pocket expenditure for women with cancer in southeast Asia: Soe Aung, Viroath Heng, Stephen Jan, Merel Kimman, Glo Cristal Luna, Htun Lwin Nyein, Corazon A Ngelange, Irisyl Orolfo Real, Win Pa Pa Naing, Somphob Sangkittipaiboon, Shridevi Subramaniam, Hasbullah Thabrany, and Cheng-Har Yip. We thank Valerie McCormack, Clara Frick, Harriet Rumgay, Doreen WH Au, Hyo-Sook Bae, Qinqin Chen, Meritxell Mallafré Larrosa, and Binbin Xu who commented on early discussions of the Commission or contributed to specific data, information, or graphics of the report. We warmly thank our advisors for their most helpful support and advice: Eduardo L Cazap, Lynette Denny, Julie Gralow, Hayley Jones, Sharon Kapambwe, Ana Langer, Devaki Nambiar, Christian Ntzimira, Solange Peters, Anna Shakarishvili, Lisa Stevens, and Richard Sullivan. We would like to express our deepest thanks to our Patient Advocacy Committee for their invaluable contributions: Piga Fernández, Nela Hasić, Kara Magsanoc-Alikpala, Gertrude Nakigudde, Abish G Romero Juárez, and Eman Shannan. Author CDT is Chair of the Patient Advocacy Committee and provided valuable advice during the conduct of the Commission. Our sincere thanks and deep gratitude for the individuals who facilitated the processes to document stories presented in the report and for the individuals who generously shared their personal stories (named or anonymously): Oumou Kassambara, Cheng Har Yip, Lama Andari, Gloria Bille, Vincent Cubaka, Marc Hagenimana, Claire Rieux, NFN Scout, Matthew B Schabath, Francois Uwinkindi, and Lydia E Pace. We would like to warmly thank Maria Castrillo Gil, Mary Guereva, and Danny Burke from eCancer for their invaluable and unwavering institutional support with the Commission's communications including website, in-person Commissioners' first meeting, and launch activities. Our sincerest thanks to Katiuska Veselinović at the IARC, for her tireless administrative work in supporting the coordination of the Commission's activities and manuscript preparation, and to Alicia A Livinski at the US National Cancer Institute for literature searches and reference management. We would also like to thank Elise M Garton and Nina Ghanem at the US National Cancer Institute for their support in the Commission's communications. We are pleased to acknowledge partners of the Commission: American Association for Cancer Research, The African Cancer for Research on End of Life Care, African Organisation for Research and Training in Cancer, American Society of Clinical Oncology, European Society for Medical Oncology, GENDRO, George Institute for Global Health, Global Focus on Cancer, International Atomic Energy Agency, IARC, International Society of Nurses in Cancer Care, Joint United Nations Programme on HIV/AIDS, Institute of Cancer Policy-King's College London, The McCabe Centre, Médecins Sans Frontières, US National Cancer Institute Center for Global Health, Latin American and Caribbean Society of Medical Oncology, The Women Global Cancer Initiative, and the Union for International Cancer Control.

PY - 2023/12/2

Y1 - 2023/12/2

UR - https://www.scopus.com/pages/publications/85173814060

U2 - 10.1016/S0140-6736(23)01701-4

DO - 10.1016/S0140-6736(23)01701-4

M3 - Review article

C2 - 37774725

AN - SCOPUS:85173814060

SN - 0140-6736

VL - 402

SP - 2113

EP - 2166

JO - The Lancet

JF - The Lancet

IS - 10417

ER -

Women, power, and cancer: a Lancet Commission

UN SDGs

Access to Document

Other files and links

Cite this